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doi:10.1016/j.ejvs.2010.09.018Abstract Objective: To investigate the indicative parameters reflecting the progression of
post-thrombotic syndrome (PTS) in patients with a first episode of deep vein thrombosis (DVT).
Design and methods: The patients’ initial risk factors were assessed at presentation. Venous
occlusion, and reflux and reflux parameters were evaluated at 6 months using venous duplex
scanning. Near-infrared spectroscopy (NIRS) was also used to measure calf muscle deoxygen-
ated haemoglobin levels at 6 months. Clinical manifestations were categorised using the clin-
ical, etiologic, anatomic and pathophysiologic (CEAP) classification for chronic venous
insufficiency (CVI), and the patients were divided into those having no PTS (C0e3S,Es,As,d,p,Pr,o)
and those having PTS (C4e6S,Es,As,d,p,Pr,o).
Results: Of the 121 patients evaluated, 25 (21%) developed PTS with a mean follow-up period
of 66 months. At initial presentation, ilio-femoral DVT (odds ratio (OR) 3.4, 95% confidence
interval (CI) 1.4e8.6) was associated with development of PTS. At 6 months, venous occlusion
combined with reflux (OR 4.4, 95% CI 2.9e20.7), peak reflux velocity >29.7 cm s1 (OR 13.7,
95% CI 4.1e45.7) and mean reflux velocity >8.6 cm s1 (OR 4.4, 95% CI 1.5e12.9) in the popli-
teal vein detected by duplex scanning were strong predictors of PTS. NIRS-derived retention
index >3.5 was the strongest predictor of PTS at 6 months (OR 67.4, 95% CI 14.3e318.1).
Conclusions: Ilio-femoral DVT is associated with the development of PTS at initial presenta-
tion. By contrast, occlusion and reflux, high reflux velocity in the popliteal vein and increased
NIRS-derived retention index are important time-course predictors of PTS progression.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3353 8111; fax: þ81 3 3225 0940.
u.ac.jp, Yamakit@aol.com (T. Yamaki).
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Factors Predicting Post-thrombotic Syndrome 127Post-thrombotic syndrome (PTS) is a common late compli-
cation of deep vein thrombosis (DVT). Typical symptoms of
PTS include pain, heaviness and skin changes ascribed to
eczema, pigmentation and ulceration. PTS has been
reported to occur in 20e40% of patients who have DVT, and
is severe in 5e10%.1,2 Recent studies have identified ipsi-
lateral recurrent DVT as a risk factor for PTS.2,3 However,
most patients with no apparent history of recurrent DVT
may also develop severe symptoms of PTS over time. For
this reason, it is difficult to reliably predict which patients
are likely to develop PTS in the acute phase of DVT.
While most studies have investigated characteristics at
the time of initial presentation, follow-up variables may
also affect the development of PTS.4,5 It is generally
believed that PTS develops as a result of venous hyper-
tension due to obstruction, valvular reflux or a combination
of the two. In the late phase, the presence of reflux in the
femoral vein (FV) and popliteal vein (POPV) is considered to
contribute to the development of PTS. In the early phase,
however, the role of venous abnormalities in these veins
has yet to be determined.
The primary purpose of the present study was to eval-
uate predictors of PTS, including baseline characteristics at
initial presentation as well as follow-up variables at a rela-
tive early stage of DVT using non-invasive examination, and
to determine the prognostic impact of these parameters on
the development of PTS.Materials and Methods
Consecutive patients with a first episode of acute symp-
tomatic unilateral DVT were potentially eligible for the
study. The patients’ initial risk factors for DVT, including
age, gender, body mass index (BMI), active cancer,
congestive heart disease, hormone replacement therapy,
immobilisation, inflammatory bowel disease, central ven-
ous catheter placement, surgery, previous history of DVT
and renal failure were all evaluated. The thrombophilia
screening in this study included protein C, protein S, anti-
thrombin III, antiphospholipid antibody and homocysteine
level. Patients with arterial insufficiency, identified on the
basis of an ankleebrachial pressure index <0.9, those with
recurrent DVT, fixed joints,muscle atrophy orweakness and
those with limb swelling due to systemic diseases or lym-
phoedema were excluded from the study. Factor V Leiden
and prothrombin G20210A were excluded because all the
study patients were Japanese.
The presence of DVT was diagnosed with duplex ultra-
sound. A colour duplex scanner (LOGIQ 7 PRO: GE Yokogawa
Medical Systems, Tokyo, Japan) with a 5e10-MHz trans-
ducer was used. Initially, each patient was placed supine in
the reverse Trendelenburg position at 15. Venous duplex
scanning was begun at the external iliac vein, common
femoral vein and then moved to the FV at the adductor
canal. The anterior and posterior tibial veins were also
recorded. Afterwards, the patient was placed prone with
the knee flexed at 30, and the residual POPV, peroneal,
gastrocnemius and soleal veins were evaluated. The diag-
nosis of DVT was based on both non-compressibility of the
vein on B-mode, and lack of spontaneous flow on colour
Doppler imaging. The common and internal iliac veins werenot investigated because these veins could not be visualised
using duplex ultrasound. The diagnosis of ilio-femoral DVT
was established if the proximal veins showed complete
occlusion with venous thrombus extending proximally to
the external iliac vein. A diagnosis of femoro-popliteal DVT
was made if the proximal veins had thrombi without iliac
involvement. Finally, a diagnosis of calf vein thrombosis
was made if thrombus was detected only in the calf veins.
After initial diagnosis, patients with proximal DVT were
treated with intravenous unfractionated heparin for 5e14
days during the acute phase, adjusted to maintain the
activated partial thromboplastin time at 1.5e2.5 times the
control value, followed by oral warfarin for at least 8 weeks
with an international normalised ratio (INR) level of 2e3.
Patients with calf vein thrombosis received oral warfarin
alone. All patients were encouraged to ambulate, and
graduated thigh-high compression stockings were applied
immediately after diagnosis.6
Evaluation of venous reflux was investigated as
described previously.7 At each examination, venous seg-
ments were assessed to determine the distribution of
thrombosis and whether they were occluded or recanalised.
Venous reflux parameters were assessed, especially in the
FV and POPV, at the 6-month follow-up point after DVT. For
evaluation of the FV, reflux was evaluated at the mid-thigh
region, and a pneumatic thigh cuff (Hokanson, Bellevue,
WA, USA) was attached to the thigh, inflated to 80 mmHg
and then rapidly deflated. For evaluation of the POPV,
reflux was evaluated at the popliteal fossa, and a cuff was
applied to the calf, inflated to 100 mmHg and then rapidly
deflated. The main duplex-derived parameters assessed
were diameter (cm), reflux times (RT; s), peak reflux
velocity (PRV; cm s1), mean reflux velocity (MRV; cm s1)
and total reflux volume (TRV; ml) calculated using the
equation: TRV (ml) Z MRV  Area (r2)  RT. The vessel
cross-sectional area was estimated from the transverse
diameter, assuming a circular vessel shape. An RT of >0.5 s
was considered to indicate incompetence.
The near-infrared spectroscopy (NIRS) technique allows
real-time monitoring of tissue oxygenation, and the details
of the examination protocol have been described pre-
viously.8e10 The patient rested supine initially with the leg
elevated on a foam block for 5 min. The patients adopted
a standing position without putting any weight on the leg
being studied, resulting in an increase in deoxygenated
haemoglobin (HHb) concentration as the veins filled. The
patient was then asked to keep still until a plateau (HHbV)
had been reached. Calf venous blood filling index (FI-HHb;
mmol(l s)1) was calculated by dividing 90% of the venous
blood volume (HHbV90) by the time taken to fill 90% of the
venous volume (HHbFT90). Then the patient was asked to
perform one tiptoe movement with weightbearing on both
legs, which produced an ejected volume (HHbEV), and then
return to the initial position, the changes in HHb being
observed. The calf venous ejection index (EI-HHb) was
calculated as HHbEI Z HHbEV/HHbV. After a new plateau
had been reached, the patient was asked to perform 10
tiptoe movements, to achieve venous expulsion (HHbE) and
a subsequent retention (HHbR). The venous retention index
(RI-HHb) was determined as HHbRI Z HHbR/HHbE. It took
approximately 4e5 min to complete the examination and
the 10 tiptoe movements were completed within 10 s.
Figure 1 Study flow diagram. In the prospective study, 154
consecutive patients were enrolled; 30 patents were excluded
and 3 were lost to follow-up, leaving 121 patients who were
eligible for the study. DVT: deep vein thrombosis, PTS: post-
thrombotic syndrome, NIRS: near-infrared spectroscopy.
Table 1 Baseline characteristics of the study patients.
Characteristics
Mean age (years), mean (SD) 65.8 S.D. 14.5
Male gender, no (%) 51 (42.1)
BMI (kg m2), mean (SD) 24.2 S.D. 3.5
Duration of oral
anticoagulation (months), mean (SD)
19.1 S.D. 8.7
Follow-up period (months), mean (SD) 66.4 S.D. 28.2
Laterality of DVT (left), no, (%) 91 (75)
Distribution of DVT, no (%)
Ilio-femoral DVT 37 (30.6)
Femoro-popliteal DVT 55 (45.4)
Calf DVT 29 (24.0)
Risk factors, no (%)
Active cancer 18 (14.9)
Central venous catheter placement 6 (5)
Congenital heart failure 3 (3)
Hormone replacement therapy 13 (11)
Immobilisation 7 (6)
Inflammatory bowel disease 3 (3)
Surgery 25 (21)
History of DVT 6 (5)
Renal failure 3 (3)
Stroke 5 (4)
Thrombophilia
Protein C deficiency 5 (4)
Protein S deficiency 4 (3)
AT III deficiency 2 (2)
Positive antiphospholipid syndrome 2 (2)
Hyperhomocysteinaemia 0 (0)
128 T. Yamaki et al.The primary endpoint of this study was the development
of PTS. In the cohort study, the follow-up protocol was an
outpatient clinic visit at 2 weeks, 1, 3 and 6 months, and
every 6 months thereafter. The duration of oral anti-
coagulation was also recorded. Final clinical manifestations
were evaluated more than 36 months after the diagnosis of
DVT. The final clinical manifestations of the study patients
were categorised according to the CEAP (clinical, etiologic,
anatomical and pathophysiologic) classification of reporting
standards of venous diseases at their last visit to the
outpatient clinic.11 All the patients had symptoms including
aching, pain, tightness, heaviness or muscle cramp to some
extent. Therefore, the patients were divided into two
groups: those having no PTS (C0e3S,Es,As,d,p,Pr,o) and those
having PTS (C4e6S,Es,As,d,p,Pr,o).
Statistical Analysis
All data were analysed using the Statistical Package for
Social Sciences (SPSS) software package (Version 16.0; SPSS
Inc., Chicago, IL, USA). Comparisons of numerical data
between groups of patients were made using Student’s t-
test. Chi-squared contingency table analysis was used to
evaluate differences between proportions. Statistical
significance was defined as p < 0.05. Receiver operating
characteristic (ROC) curves were used to assess the
predictive power of NIRS-derived parameters. Variables
with p < 0.10 were selected as confounding predictors of
PTS and were tested using multiple logistic regression
analysis.
Results
Overall, 154 consecutive patients were enrolled into the
prospective study. Among them, 30 were rejected on the
basis of the exclusion criteria and three were lost to follow-
up. The remaining 121 patients were eligible for the study
(Fig. 1).
Tables 1 and 2 show the baseline characteristics of the
study patients. There was no significant difference in the
laterality of DVT. DVT was located in the ilio-femoral
segment in 30.6% of patients, the femoro-popliteal segment
in 45.4% and the calf in 24%. DVT occurred most commonly
after surgery (25 patients, 21%), followed by active cancer
(18 patients, 15%) and hormone replacement therapy (13
patients, 11%). At initial assessment, all the patients had
symptoms including aching, pain, tightness, heaviness or
muscle cramps to some extent. Of these patients, 99 (82%)
presented with limb swelling. The final clinical manifesta-
tions of the study patients were assessed at a mean of 66.4
months after DVT. Of the 121 patients evaluated, 25 (21%)
had PTS. However, the remaining 96 (79%) did not have any
post-thrombotic sequelae.
Table 3 shows the differences in the baseline character-
istics between the patients with and without PTS. The
proportion of ilio-femoral DVT was significantly higher in
patients who developed PTS than in patients who did not
(p < 0.0001). By contrast, patients with calf DVT were
significantly less likely to develop PTS (p Z 0.009). There
were no significant differences in age, gender, BMI, duration
of anticoagulation and risk factors between the two groups.
Table 2 Number of patients in each CEAP (clinical, etiologic, anatomic, and pathophysiological) clinical classification -
Baseline and final assessment at 66 months.
Class Signs and symptoms Patients (n)
Baseline assessment Final assessment
C0 No visible or palpable signs of venous disease 17 64
C1 Telangiectases or reticular veins 3 10
C2 Varicose veins; distinguished from reticular
veins by a diameter of 3 mm or more
2 12
C3 Edema 99 10
C4a Pigmentation or eczema 16
C4b Lipodermatosclerosis or atrophie blanche 4
C5 Healed venous ulcer 3
C6 Active venous ulcer 2
Factors Predicting Post-thrombotic Syndrome 129The distribution of venous abnormalities is presented in
Table 4. The proportion of patients with occlusion alone did
not differ between the groups. Similarly, the presence of
reflux alone did not differ significantly between the groups.
By contrast, the proportion of patients with both reflux andTable 3 Differences in the characteristics and risk factors fo
syndrome.
No PTS
n Z 96
Characteristics
Mean age (yr) 66.1 S.D
Male gender, no (%) 39 (40.6
BMI (kg/m2) 23.8 S.D
Duration of oral anticoagulation (months) 18.9 S.D
Laterality of DVT (left), no (%) 73 (76)
Distribution of DVT, no (%)
Ilio-femoral DVT 24 (25)
Femoro-popliteal DVT 44 (46)
Calf DVT 28 (29)
Risk factors, no (%)
Active cancer 15 (16)
Central venous catheter placement 5 (5)
Congenital heart failure 2 (2)
Hormone replacement therapy 10 (10)
Immobilisation 5 (5)
Inflammatory bowel disease 3 (3)
Surgery 23 (24)
History of DVT 5 (5)
Renal failure 3 (3)
Stroke 4 (4)
Thrombophilia 11 (12)
Protein C deficiency 4 (4)
Protein S deficiency 3 (3)
AT III deficiency 2 (2)
Positive antiphospholipid syndrome 2 (2)
Hyperhomocysteinemia 0 (0)
CVI: chronic venous insufficiency, DVT: deep vein thrombosis, PTS: po
a Student’s t-test. Valuables expressed as mean and SD.
b Pearson’s chi-squared test.obstruction was significantly higher in PTS patients
(p < 0.0001).
Table 5 shows the duplex-derived venous reflux param-
eters in the FV and POPV and NIRS-derived parameters at
the 6-month follow-up point. There were no significantr DVT between patients with and without post-thrombotic
patients
PTS
n Z 25 patients
p-value
. 14.7 64.3 S.D. 13.7 N.S.a
) 12 (48.0) N.S.b
. 3.9 25.0 S.D. 4.8 N.S.a
. 8.6 21.2 S.D. 8.9 N.S.a
18 (72) N.S.b
13 (52) <0.0001b
11 (44) N.S.b
1 (4) 0.009b
3 (12) N.S.b
1 (4) N.S.b
1 (4) N.S.b
3 (12) N.S.b
2 (8) N.S.b
0 (0) N.S.b
2 (8) N.S.b
1 (4) N.S.b
0 (0) N.S.b
1 (4) N.S.b
2 (8) N.S.b
1 (4) N.S.b
1 (4) N.S.b
0 (0) N.S.b
0 (0) N.S.b
0 (0) N.S.b
st-thrombotic syndrome, NS: not significant.
Table 4 Distribution of venous abnormalities at the 6-month follow-up point.
Distribution of venous
abnormalities, no (%)
No PTS
n Z 96 patients
PTS
n Z 25 patients
P-valuea
No abnormality 36 (38) 1 (4) 0.001
Occlusion alone 11 (13) 1 (4) N.S.
Reflux alone 25 (26) 6 (20) N.S.
Occlusion with/without reflux
and reflux with/without
occlusion
24 (25) 17 (68) <0.0001
CVI: chronic venous insufficiency, PTS: post-thrombotic syndrome, NS: not significant.
a Pearson’s chi-squared test.
130 T. Yamaki et al.differences in any of duplex-derived reflux parameters in
the FV. On the other hand, PRV in the POPV had significant
power to discriminate between the two groups
(p Z 0.0008). Similarly, MRV in the POPV was significantly
higher in patients with PTS than in those without PTS
(p Z 0.030).
With regard to NIRS-derived parameters, there were no
significant differences in the values of FI and EI between
the groups (Table 5). By contrast, the value of RI was
significantly higher in patients with PTS than in those
without (p < 0.0001).
Using duplex-derived PRV and MRV in the POPV as
analytical parameters, a separate ROC curve analysis was
conducted, and the most suitable cut-off points with the
highest accuracy, minimal false negativity and false posi-
tivity for discrimination between the two groups were
identified (Fig. 2(A)). First, using an optimal cut-off pointTable 5 Duplex-derived reflux parameters in the femoral vein (
Parameters No PTS
n Z 96 patients
Duplex-derived reflux parameters, mean (SD)
FV 15 limbs
Diameter (cm) 0.79 S.D. 0.14
Reflux times (s) 4.57 S.D. 2.04
Peak reflux velocity (cm s1) 21.1 S.D. 10.4
Mean reflux velocity (cm s1) 9.7 S.D. 6.4
Total reflux velocity (mL) 35.6 S.D. 37.6
POPV 46 limbs
Diameter (cm) 0.80 S.D. 0.16
Reflux times (s) 4.13 S.D. 2.73
Peak reflux velocity (cm s1) 19.8 S.D. 9.9
Mean reflux velocity (cm s1) 8.0 S.D. 4.8
Total reflux velocity (mL) 24.6 S.D. 23.9
Near-infrared spectroscopy-
derived parameters
96 limbs
FI (mmol/L s) 0.18 S.D. 0.16
EI 0.37 S.D. 0.24
RI 2.38 S.D. 2.70
CVI: chronic venous insufficiency, FI: filling index (FI-HHb), EI: ejecti
botic syndrome.
a Student’s t-test. Valuables expressed as mean and SD.of 29.7 cm s1, PRV showed strong ability to predict the
development of PTS with a sensitivity of 62.5%, a speci-
ficity of 87%, a positive predictive value of 71.4% and
a negative predictive value of 81.6% (area under the curve
0.77, 95% confidence interval (CI) 0.65e0.86, pZ 0.0001).
Second, when a MRV cut-off point of 8.6 cm s1 was used,
the clinical discrimination performance was also signifi-
cant with a sensitivity of 62.5%, a specificity of 69.6%,
a positive predictive value of 51.7% and a negative
predictive value of 78% (area under the curve 0.68, 95% CI
0.56e0.79, p Z 0.009). Finally, using the NIRS-derived RI
for ROC curve analysis, a cut-off value of 3.5 was shown to
have the strongest power to discriminate between
patients with and without PTS (Fig. 2(B)), with a sensitivity
of 92%, a specificity of 85.4%, a positive predictive value of
62.1% and a negative predictive value of 97.6% (area under
the curve 0.95, 95% CI 0.89e0.98, p Z 0.0001).FV) and popliteal vein (POPV), and NIRS-derived parameters.
PTS
n Z 25 patients
p-valuea
13 limbs
0.73 S.D. 0.13 N.S.
4.20 S.D. 1.77 N.S.
25.5 S.D. 6.0 N.S.
11.0 S.D. 2.6 N.S.
26.5 S.D. 13.2 N.S.
24 limbs
0.78 S.D. 0.13 N.S.
3.42 S.D. 1.92 N.S.
31.4 S.D. 12.3 0.0008
11.1 S.D. 5.0 0.030
29.3 S.D. 29.1 N.S.
25 limbs
0.12 S.D. 0.11 N.S.
0.32 S.D. 0.22 N.S.
12.26 S.D. 15.26 <0.0001
on index (EI-HHb), RI: retension index (RI-HHb) PTS: post-throm-
Figure 2 Ability of duplex-derived peak reflux velocity (PRV),
mean reflux velocity (MRV) in the popliteal vein, and near-
infrared spectroscopy-derived venous retention index (RI) to
predict PTS. A. The blue line denotes the PRV (area under the
curve 0.77, 95% confidence interval 0.65e0.86, P Z 0.0001)
with a sensitivity of 62.5%, a specificity of 87%, a positive
predictive value of 71.4%, and a negative predictive value of
81.6%. The green line denotes the MRV with a sensitivity of
62.5%, a specificity of 69.6%, a positive predictive value of
51.7%, and a negative predictive value of 78% (area under the
curve 0.68, 95% confidence interval 0.56e0.79, p Z 0.009). B.
An optimal cut-off point of 3.5 for RI showed the strongest
ability to predict the development of PTS, with a sensitivity of
92%, a specificity of 85.4%, a positive predictive value of 62.1%,
and a negative predictive value of 97.6% (area under the curve
0.95, 95% confidence interval 0.89e0.98, p Z 0.0001).
Factors Predicting Post-thrombotic Syndrome 131The confounding predictors of PTS were finally tested
using multivariate analysis (Table 6). At initial presentation,
initial thrombus involvement of the ilio-femoral segmentwas
significantly associated with severe symptoms of PTS (odds
ratio (OR) 3.44, 95% CI 1.38e8.58, pZ 0.008). By contrast,
calf DVT was independently associated with a lower preva-
lence of PTS (OR 0.10, 95% CI 0.01e0.79, pZ 0.028).At the 6-month point, patients lacking venous abnormal-
itieswere significantly unlikely to develop PTS symptoms (OR
0.07, 95% CI 0.01e0.54, p Z 0.011). By contrast, venous
occlusion combined with reflux was independently predic-
tive of PTS (OR 4.40, 95% CI 2.87e20.72, p < 0.0001).
PRV > 29.7 cm s1 in the POPV was the strongest duplex-
derived predictor of PTS (OR 13.67, 95% CI 4.09e45.65,
p < 0.0001), followed by MRV > 8.6 cm s1 in the POPV (OR
4.36, 95% CI 1.53e12.89, p Z 0.006). RI > 3.5 detected by
NIRS was the strongest predictor of PTS at the 6-month
follow-up point (OR 67.36, 95%CI 14.26e318.06, p< 0.0001).Discussion
This study confirmed the possible predictors of disease
progression in patients with a first episode of DVT. Our main
findings were that (1) the involvement of the ilio-femoral
segment was significantly associated with severe symptoms
of PTS at initial presentation. At the 6-month follow-up
point, we found that (2) venous occlusion combined with
reflux was independently predictive of PTS, (3) PRV >
29.7 cm s1 in the POPV was the strongest predictor of PTS
(OR 13.67, 95% CI 4.09e45.65, p < 0.0001) followed by
MRV > 8.6 cm s1 in the POPV (OR 4.36, 95% CI 1.53e12.89,
pZ 0.006) and (4) an optimal cut-off point of 3.5 for NIRS-
derived RI showed the strongest ability to predict the
deterioration of PTS symptoms (OR 67.36, 95% CI
14.26e318.06, p < 0.0001).
Although many risk factors for DVT have been identified
to date, the only risk factors identified previously for PTS
have been ipsilateral recurrence of DVT2,3 and increased
BMI.12e15 Increased age has also been proven to be associ-
ated with a higher risk of DVT, but appears to have no
definite association with PTS.16e18 The presence of factor V
Leiden or prothrombin gene mutation is reportedly an
independent predictor of a lower risk of PTS.18
The initial distribution of DVT may affect the clinical
progression of the disease. The risk of PTS is reportedly
higher in patients with proximal rather than distal DVT.13
Furthermore, patients with acute ilio-femoral DVT
develop the most severe post-thrombotic sequelae.19 A
recent prospective, multicentre study of predictors of PTS
in North America demonstrated that patients with more
severe post-thrombotic manifestations 1 month after DVT
had a poorer long-term outcome over 2 years, suggesting
that the persistence of venous symptoms and signs at 1
month may be attributable to residual venous thrombosis,
especially in the ilio-femoral venous segment.20 In the
present study, ilio-femoral DVT was only predictive of PTS.
In the late phase, reflux in the proximal deep veins
contributed significantly to the development of PTS.21
However, the association between the progression of PTS
and the role of venous abnormalities in the early phase has
yet to be determined. Previous studies showed that valve
incompetence developed most frequently in segments that
had been initially affected by thrombi, and that less valve
damage was evident in the calf vein segment. The incom-
petence in segments without initial documented throm-
bosis may be the result of unnoticed thrombus propagation.
The development of reflux in a specific segment will be
due, in most cases, to the damage caused to the valve by
Table 6 Final predictors of PTS.
Variables Odds ratio (95% confidence interval) p-value
Predictors at initial presentation
Distribution of DVT
Ilio-femoral DVT 3.44 (1.38e8.58) 0.008
Calf DVT 0.10 (0.01e0.79) 0.028
Predictors at 6 months follow-up
Venous abnormality
No abnormality 0.07 (0.01e0.54) 0.011
Occlusion þ reflux 4.40 (2.87e20.72) <0.0001
Duplex-derived reflux
parameters
Cut-off point Odds ratio (95%
confidence interval)
p-value
Popliteal vein
Peak reflux velocity
(cm s1)
>29.7 13.67 (4.09e45.65) <0.0001
Mean reflux velocity
(cm s1)
>8.6 4.36 (1.53e12.89) 0.006
NIRS-derived parameter Cut-off point Odds ratio (95%
confidence interval)
p-value
RI >3.5 67.36 (14.26e318.06) <0.0001
DVT: deep vein thrombosis, NIRS: near-infrared spectroscopy, RI: retension index (RI-HHb).
132 T. Yamaki et al.the thrombotic process.22,23 These findings are in accord
with those of the present study.
In a previous study, we found that reflux in the proximal
deep veins was an important contributor to severe symp-
toms of PTS at the 2-year follow-up point.24 Furthermore,
we showed that the presence of reflux as reflected by an
elevated PRV in the POPV (>25.4 cm s1) and FV
(>24.5 cm s1) was an independent predictor of PTS at 2
years after DVT.22 In the present study, however, the
presence of reflux alone was not predictive of PTS at 6
months after DVT. Despite the fact that PRV and MRV in the
FV were unlikely to predict the development of PTS, these
parameters in the POPV were predictive of PTS at 6 months.
The optimal cut-off points for PRV and MRV in the POPV
were relatively higher, with a lower OR, in the present
study than those at 2 years in our previous study, suggesting
poorer luminal recanalisation in the proximal veins at the 6-
month follow-up point.
Among the parameters evaluated in this study, NIRS-
derived RI> 3.5 was the strongest predictor of deterioration
of PTS symptoms. Our previous study of the use of NIRS-
derived parameters for clinical prediction of PTS found that
(1) FI and RI measured by NIRS appeared to be promising for
prediction of PTS after DVT, (2) EI measured by NIRS was
significantly more reduced in patients with proximal DVT
than in those with calf DVT, (3) RI was significantly more
increased in patients with ilio-femoral DVT than in those
with calf DVT and (4) an optimal cut-off point of 2.9 for
HHbRI had a strong capability for predicting PTS.8 These
factors might reflect diminished calf muscle pump function
as a result of pre-existing venous obstruction, venous reflux
or a combination of the two, leading to higher ambulatory
venous pressure and development of PTS.
Our present study had some limitations. First, it had
a limited sample size,whichmay have introduced a potentialfor type II statistical error. Further analysis of the risk of PTS
was difficult to perform (e.g., comparison by decade of age
and by BMI according to the criteria of the World Health
Organization). A large sample size will, therefore, be
required to confirm the relationship between the investi-
gated parameters and clinical outcome. Second, we did not
investigate the effect of reflux in the superficial venous
system. Labropoulos et al. reported that 47% of patients with
symptomatic PTS had both superficial and deep venous
insufficiency.25 However, superficial vein incompetence will
appear over time, and our previous study did not confirm any
significant role of superficial venous reflux for predicting the
development of PTS at the 2-year follow-up point.21 Third,
we excluded patients with recurrent DVT, even though it is
recognised as a high-risk factor for PTS. Because duplex- and
NIRS-derived parameters will change after the development
of recurrent DVT, the relationship between the initial
distribution of DVT and these parameters might have been
concealed. Nevertheless, our study clearly demonstrated
the significance of duplex- and NIRS-derived parameters at
the 6-month follow-up point as prognostic variables in
patients with a first episode of DVT. Finally, despite the
considerable incidence of PTS encountered in clinical prac-
tice, an objective assessment of its severity is still difficult.
Airplethysmography (APG) could be used to evaluate ambu-
latory venous function, but APG parameters do not correctly
reflect data obtained in the presence of proximal occlusion.
By contrast, venous occlusion does not affect NIRS-derived
parameters. We previously tried to correlate APG-derived
parameters with NIRS-derived ones, but found there were no
significant relationships between venous filling index and FI-
HHb, ejection fraction and EI-HHb or residual volume frac-
tion and RI-HHb (unpublished data).9
In conclusion, we detected symptoms of PTS in 20.7% of
patients with a first episode of DVT. The ilio-femoral DVT at
Factors Predicting Post-thrombotic Syndrome 133initial presentation was associated with the development of
PTS. By contrast, occlusion and reflux in the proximal deep
vein, duplex-derived high PRV (>29.7 cm s1) and high MRV
(>8.6 cm s1) in the POPV and increased NIRS-derived RI
(>3.5) were important time-course predictors of the
deterioration of PTS symptoms. These results appear to
reflect the possibility that a high reflux velocity in the POPV
and increased calf muscle deoxygenation during exercise
are suggestive of future venous malfunction in patients
with a first episode of DVT.
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